Germany· DE-A57-d862a4892106e085
Teveten
A eprosartan product containing eprosartan, registered in Germany by Viatris Healthcare Gmbh. The same ATC class is registered in 8 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Eprosartan is registered in 8 of 19 countries.
Countries holding a registration under ATC C09CA02 (eprosartan), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Eprosartan · ATC C09CA02
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- United Kingdom
Price per daily dose
What a daily dose of eprosartan costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eprosartan · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- ES Spain$0.58
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Eprosartan
- Manufacturer
- Viatris Healthcare Gmbh
- Country
- Germany (DE)
- ATC code
- C09CA02
- ATC class
- Eprosartan
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
201 interactions on record for eprosartan.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eprosartan · interactions on record
201 records
- 7 severe
- 113 moderate
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eprosartan in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEprosartan 300mg tabletsManx Healthcare Ltd
- FinlandEprosartan MylanMylan AB
- SpainEPROSARTAN MYLAN PHARMACEUTICALS 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGMylan Pharmaceuticals S.L.
- BelgiumTeveten 300 mgViatris
- IrelandTEVETEN 400 mg, film-coated tabletsViatris Healthcare Limited
- NetherlandsTeveten 400, filmomhulde tabletten 400 mgViatris Healthcare B.V.
- NorwayTevetenViatris AS
- SwedenTeveten 600 mg Filmdragerad tablettViatris AB
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Teveten
- Belgium · Teveten
- Bulgaria · Теветен
- Spain · Futuran, Navixen
- Finland · Teveten
- United Kingdom (Northern Ireland) · Eprosartan Activase Pharmaceuticals, Eprosartan Amarox
- Greece · Teveten
- Ireland · Teveten
- Luxembourg · Teveten
- Netherlands · Teveten
- Norway · Teveten
- Portugal · Teveten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f827643a-644f-4630-830f-18939925fc55 GET /v1/drugs/f827643a-644f-4630-830f-18939925fc55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Eprosartan",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about eprosartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.